S. Phang

T cell-depleted granulocyte colony-stimulating factor (G-CSF) modified allogeneic bone marrow transplantation for hematological malignancy improves graft CD34+ cell content but is associated with delayed pancytopenia

A. Raptis, C. Dunbar, E. Read, 1998, Bone Marrow Transplantation.

T cell-depleted bone marrow transplantation and delayed T cell add-back to control acute GVHD and conserve a graft-versus-leukemia effect

N. Young, A. Barrett, J. Tisdale, 1998, Bone Marrow Transplantation.

High incidence of adeno- and polyomavirus-induced hemorrhagic cystitis in bone marrow allotransplantation for hematological malignancy following T cell depletion and cyclosporine

S. Rosenfeld, A. Barrett, R. Childs, 1998, Bone Marrow Transplantation.

Circulating basic fibroblast growth factor declines during Cy/TBI bone marrow transplantation

P. Okunieff, P. Rubin, L. Constine, 1999, Bone Marrow Transplantation.

High-dose corticosteroid therapy for diffuse alveolar hemorrhage in allogeneic bone marrow stem cell transplant recipients

A. Raptis, R. Childs, A. Suffredini, 1999, Bone Marrow Transplantation.

Shifts in the skin bacterial and fungal communities of healthy children transitioning through puberty.

H. Kong, J. Segre, J. Yanovski, 2021, The Journal of investigative dermatology.

Nonmyeloablative conditioning followed by transplantation of genetically modified HLA-matched peripheral blood progenitor cells for hematologic malignancies in patients with acquired immunodeficiency syndrome.

R. Morgan, A. Barrett, J. Tisdale, 2002, Blood.

malignancies in patients with acquired immunodeficiency syndrome modified HLA-matched peripheral blood progenitor cells for hematologic Nonmyeloablative conditioning followed by transplantation of genetically

R. Morgan, R. Childs, H. Malech, 2013 .